• 제목/요약/키워드: P-median

검색결과 2,058건 처리시간 0.025초

임상적으로 진단된 수근관증후군 환자에서 F파 분석 (F-Wave Analysis in Patients with Clinically Diagnosed Carpal Tunnel Syndrome)

  • 김성희;유봉구;김광수;유경무
    • Annals of Clinical Neurophysiology
    • /
    • 제4권2호
    • /
    • pp.108-113
    • /
    • 2002
  • Background and Objective : Carpal tunnel syndrome (CTS) is the most common mononeuropathy encountered in clinical practice. No single procedure or group of procedures has demonstrated adequate sensitivity. F-wave study in CTS is very rarely reported. To determine the diagnostic usefulness of new parameters of F-wave and comparative study of F-wave parameters of median and ulnar nerves in patients with CTS. Methods : F-wave responses of median and ulnar nerves were analyzed from 27 patients with clinically diagnosed CTS and 22 age and gender-matched normal control. Conventional F-wave parameters were studied. Also, the usefulness of new parameters such as mean and maximal ulnar-median F-wave latency differences, ulnar-median F-wave persistence and chronodispersion differences, median/ulnar F-wave amplitude ratio, and F-wave conduction velocity (FCV) using mean and maximal latency were assessed. Results : Compared with controls, median F-wave minimal, maximal and mean latencies, mean F-wave amplitude/M-wave amplitude, minimal, mean and maximal ulnar-median F-wave latency differences, and FCVs using minimal, maximal and mean latency were significant (P<0.05~0.001). Median F-wave minimal, maximal and mean latencies, mean ulnar-median F-wave latency difference, and FCVs using minimal, maximal and mean latency showed high sensitivity and specificity. Mean ulnar-median F-wave latency difference and FCVs using maximal and mean latency were new parameters. Conclusion : New F-wave parameter including mean ulnar- median F-wave latency difference and FCVs using maximal and mean latency may be a useful to assess the CTS. Also, median F-wave minimal, maximal and mean latencies, and FCV using minimal latency may be included in routine diagnostic tests in CTS.

  • PDF

Prognostic Factors and Clinical Outcome in Parotid Gland Tumors: a Single Institution Experience from the Eastern Black Sea Region of Turkey

  • Kandaz, Mustafa;Soydemir, Gulsen;Bahat, Zumrut;Canyilmaz, Emine;Yoney, Adnan
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제17권3호
    • /
    • pp.1169-1174
    • /
    • 2016
  • Purpose: To review clinical characteristics, treatment outcomes and prognostic factors in patients with parotid gland tumors treated with surgery and postoperative radiotherapy. Materials and Methods: We retrospectively reviewed 69 patients with parotid gland tumors, with a median follow-up of 52 months (range, 2-228 months). and a median radiotherapy dose of 60Gy (range, 30-69 Gy). Results: There were 24 (35%) females and 45 (65%) males, at a ratio of 1/1.9. Median age at presentation was $58.9{\pm}17.2$ (range 13-88) years. The most common histology was adenoid cystic carcinoma (33%) and mucoepidermoid carcinoma (28%). The mean overall survival (OS) was $65.3{\pm}8$ (95% confidence interval [CI], 49.6-81.1) months and the median overall survival was $40.0{\pm}7$ (95% CI, 26.2-53.7) months. The -1, -3, -5 and -10 year OS rates were 78%, 52.4%, 35.3% and 19.6% respectively. The mean disease free survival (DFS) was $79.2{\pm}10$ (95% CI, 59.3-97.1) months and the median disease free survival was $38{\pm}13$ (95% CI, 7.05-88.7) months. The -1,-3,-5 and -10 year DFS rates were 71.9%, 50.1%, 43.7% and 30.1% respectively. On univariate analysis, the OS was significantly better with female sex (p<0.005), < 50 age (p<0.021), T stage (p<0.0001), absence of lymph node involvement (p<0.0001), lower tumor grade (p<0.0001), absence of lymphovascular invasion (p<0.002), absence of perineural invasion (p<0.0001), absence of extracapsuler extension (p<0.0001), surgical margin negativity (p<0.006), ${\leq}60Gy$ radiotherapy dose (p<0.0001) and absence of distant metastasis (p<0.027). Conclusions: Employing existing standards of postoperative radiotherapy is a possible treatment that was found to be mainly effective in patients with parotid gland carcinomas.

Comparison of mortality between open and closed pelvic bone fractures in Korea using 1:2 propensity score matching: a single-center retrospective study

  • Jaeri Yoo;Donghwan Choi;Byung Hee Kang
    • Journal of Trauma and Injury
    • /
    • 제37권1호
    • /
    • pp.6-12
    • /
    • 2024
  • Purpose: Open pelvic bone fractures are relatively rare and are considered more severe than closed fractures. This study aimed to compare the clinical outcomes of open and closed severe pelvic bone fractures. Methods: Patients with severe pelvic bone fractures (pelvic Abbreviated Injury Scale score, ≥4) admitted at a single level I trauma center between 2016 and 2020 were retrospectively analyzed. Patients aged <16 years and those with incomplete medical records were excluded from the study. The patients were divided into open and closed fracture groups, and their demographics, treatment, and clinical outcomes were compared before and after 1:2 propensity score matching. Results: Of the 321 patients, 24 were in the open fracture group and 297 were in the closed fracture group. The open fracture group had more infections (37.5% vs. 5.7%, P<0.001) and longer stays in the intensive care unit (median 11 days, interquartile range [IQR] 6-30 days vs. median 5 days, IQR 2-13 days; P=0.005), but mortality did not show a statistically significant difference (20.8% vs. 15.5%, P=0.559) before matching. After 1:2 propensity score matching, the infection rate was significantly higher in the open fracture group (37.5% vs. 6.3%, P=0.002), whereas the length of intensive care unit stay (median 11 days, IQR 6-30 days vs. median 8 days, IQR 4-19 days; P=0.312) and mortality (20.8% vs. 27.1%, P=0.564) were not significantly different. Conclusions: The open pelvic fracture group had more infections than the closed pelvic fracture group, but mortality was not significantly different. Aggressive treatment of pelvic bone fractures is important regardless of the fracture type, and efforts to reduce infection are important in open pelvic bone fractures.

등척성 요추 신전운동 시 중앙주파수와 토크의 특성 (Characteristics of EMG Median Frequency and Torque During Isometric Back Extension Exercises)

  • 강성재;박세진;장근;박경희;권오윤;김영호
    • 대한의용생체공학회:의공학회지
    • /
    • 제23권1호
    • /
    • pp.9-16
    • /
    • 2002
  • 국부적 근 피로는 근전도 신호의 저주파역으로의 천이, 특히 중앙주파수의 감소로 특징된다. 여러 운동각도(0$^{\circ}$, 12$^{\circ}$, 36$^{\circ}$, 72$^{\circ}$)에서 등척성 요추신전운동을 수행하는 동안 근 피로에 따른 근전도 신호의 중앙주파수와 토크의 특성을 살펴보고자 총 20명 (평균 연령 24.35$\pm$2.70세)의 건강i한 피검자를 대상으로 본 실험연구를 수행하였다. 근전도 신호로부터 FFT를 사용하여 중앙주파수를 추출하였으며 선형회귀분석을 통해서 시간에 따른 초기중앙주파수의 초기값과 기울기를 계산하였다. 중앙주파수의 기울기와 토크의 기울기에 대한 상관관계를 정량화하기 위해서 피어슨 상관계수를 적용하였다 중앙주파수의 기울기(p〈0.656)나 v-절편(p〈0.609), 피로지수(p〈0.555)에서는 요추의 각도 타이에 영향을 받지 않아 유의한 차이가 없었으며. 토크의 기울기. 피로지수 역시 유의한 차이가 없었으나, 토크의 y-절편에서는 차이(p〈0.04)가 나타나서, 근육의 길이 증가와 자세변화가 토크에 영향을 미침을 알 수 있었다. 또한, 개인간의 중앙주파수와 토크의 기울기에는 상관관계가 낮았으나, 개인 내에서 중앙주파수와 토크의 시계열 변화에는 유의한 상관관계(0.682)가 있음을 알 수 있었다.

Estimation of Median in the Presence of Three Known Quartiles of an Auxiliary Variable

  • Singh, Housila P.;Shanmugam, Ramalingam;Singh, Sarjinder;Kim, Jong-Min
    • Communications for Statistical Applications and Methods
    • /
    • 제21권5호
    • /
    • pp.363-386
    • /
    • 2014
  • This paper has improved several ratio type estimators of the population median including their generalization in the presence of three known quartiles of an auxiliary variable. The properties of the improved estimators are discussed and applied. Both the empirical and simulation studies confirm that our new estimators perform efficiently.

Role of salvage radiotherapy for regional lymph node recurrence after radical surgery in advanced gastric cancer

  • Kim, Byoung Hyuck;Eom, Keun-Yong;Kim, Jae-Sung;Kim, Hyung-Ho;Park, Do Joong
    • Radiation Oncology Journal
    • /
    • 제31권3호
    • /
    • pp.147-154
    • /
    • 2013
  • Purpose: To evaluate the role of salvage radiotherapy (RT) for the treatment of regional lymph node recurrence (RLNR) after radical surgery in advanced gastric cancer. Materials and Methods: We retrospectively analyzed medical records of 26 patients who underwent salvage treatment after diagnosis of RLNR between 2006 and 2011. Patients with peritoneal seeding or distant metastasis were excluded. Eighteen patients received RT with or without chemotherapy and the other 8 did chemotherapy only without RT. A three-dimensional conformal RT was performed with median dose of 56 Gy (range, 44 to 60 Gy). Sixteen patients had fluoropyrimidine-based chemotherapy, 5 did taxane-based chemotherapy, and irinotecan was applied in 4. Results: With a median follow-up of 20 months (range, 5 to 57 months), median overall survival (OS) and progression-free survival (PFS) after diagnosis of RLNR were 29 months and 12 months in the entire patients, respectively. Radiotherapy (p = 0.007) and disease-free interval (p = 0.033) were statistically significant factors for OS in multivariate analysis. Median OS was 36 months in patients who received RT and 16 months in those who did not. Furthermore, delivery of RT (p < 0.001), complete remission after salvage treatment (p = 0.040) and performance status (p = 0.023) were associated with a significantly better PFS. Gastrointestinal toxicities from RT were mild in most patients. Conclusion: Salvage RT combined with systemic chemotherapy may be an effective treatment managing RLNR from advanced gastric cancer.

A Retrospective Study on Canine Epilepsy: Etiological Distribution, Therapeutic Outcome, and Survival Time

  • Park, Seo-Yeon;Jeong, Yoonsoo;Yun, Taesik;Jung, Dong-In;Chang, Dong-Woo;Kang, Ji-Houn;Yang, Mhan-Pyo;Kang, Byeong-Teck
    • 한국임상수의학회지
    • /
    • 제36권3호
    • /
    • pp.150-154
    • /
    • 2019
  • The purpose of this study was to investigate the etiological distribution, therapeutic outcome, and survival time in canine epilepsy. The medical records of 57 epileptic dogs were reviewed for the evaluation of etiological distribution. Among them, 27 dogs (47%) and 30 dogs (52%) had idiopathic epilepsy (IdE) and structural epilepsy (StE), respectively. Twenty-nine dogs (IdE: 16 dogs, StE: 13 dogs) were evaluated for therapeutic outcome and survival time. The incidence of generalized epileptic seizure (IdE, 56% vs. StE, 44%; P = 0.043) and the median seizure frequency at the time of first presentation (IdE, 2.0/month vs. StE, 13.3/month; P < 0.01) were significantly different between the two groups. Although pre-treatment seizure frequency and duration were not different, the median duration of seizure in the IdE group (0.5 min) was significantly shorter than that in the StE group (3 min) after treatment (P < 0.01). In addition, the median frequency of seizure was relatively lower in the IdE group (0.25/month) compared to the StE group (2.00/month) following antiepileptic therapy (P = 0.053). The median survival time of the IdE group (1.5 years [95% CI, 1.0-2.3 years]) was significantly longer than that of the StE group (0.4 year [95% CI, 0.2-1.3 years]) (P < 0.01). The information on etiological data and intracranial lesions may be useful for predicting treatment response and prognosis in epileptic dogs.

Consecutive versus concomitant follicle-stimulating hormone and highly purified human menopausal gonadotropin: A milder response but better quality

  • Maghraby, Hassan Ali;Agameya, Abdel Fattah Mohamed;Swelam, Manal Shafik;El Dabah, Nermeen Ahmed;Ahmed, Ola Youssef
    • Clinical and Experimental Reproductive Medicine
    • /
    • 제49권2호
    • /
    • pp.135-141
    • /
    • 2022
  • Objective: This study investigated the impact of two stimulation protocols using highly purified human menopausal gonadotropin (HP-hMG) on the endocrine profile, follicular fluid soluble Fas levels, and outcomes of intracytoplasmic sperm injection (ICSI) cycles. Methods: This prospective clinical trial included 100 normal-responder women undergoing ovarian stimulation for ICSI; 55 patients received concomitant follicle-stimulating hormone (FSH) plus HP-hMG from the start of stimulation, while 45 patients received FSH followed by HP-hMG during mid/late follicular stimulation. The primary outcome was the number of top-quality embryos. The secondary outcomes were the number and percentage of metaphase II (MII) oocytes and the clinical pregnancy rate. Results: The number of MII oocytes was significantly higher in the concomitant protocol (median, 13.0; interquartile range [IQR], 8.5-18.0 vs. 9.0 [8.0-13.0] in the consecutive protocol; p=0.009); however, the percentage of MII oocytes and the fertilization rate were significantly higher in the consecutive protocol (median, 90.91; IQR, 80.0-100.0 vs. 83.33 [75.0-93.8]; p=0.034 and median, 86.67; IQR, 76.9-100.0 vs. 77.78 [66.7-89.9]; p=0.028, respectively). No significant between-group differences were found in top-quality embryos (p=0.693) or the clinical pregnancy rate (65.9% vs. 61.8% in the consecutive vs. concomitant protocol, respectively). The median follicular fluid soluble Fas antigen level was significantly higher in the concomitant protocol (9,731.0 pg/mL; IQR, 6,004.5-10,807.6 vs. 6,350.2 pg/mL; IQR, 4,382.4-9,418.4; p=0.021). Conclusion: Personalized controlled ovarian stimulation using HP-hMG during the late follicular phase led to a significantly lower response, but did not affect the quality of ICSI.

An assignment method for part-machine cell formation problem in the presence of multiple process routes

  • Won, You-Kyung;Kim, Sehun
    • 한국경영과학회:학술대회논문집
    • /
    • 대한산업공학회/한국경영과학회 1994년도 춘계공동학술대회논문집; 창원대학교; 08월 09일 Apr. 1994
    • /
    • pp.236-243
    • /
    • 1994
  • In this paper we consider the part-machine cell formation decision of the generalized Group Technology(GT) problem in which multiple process routes can be generated for each part. The existing p-median model and similarity coefficient algorithm can solve only small-sized or well-structured cases. We suggest an assignment method for the cell formation problem. This method uses an assignment model which is a simple linear programming. Numerical examples show that our assignment method provides good separable cells formation even for large-sized and ill-structured problems.

핵의학 체외검사실에서 시약 lot간 parallel test 시 변이 분석 (Analysis of Variation for Parallel Test between Reagent Lots in in-vitro Laboratory of Nuclear Medicine Department)

  • 채홍주;천준홍;이선호;유소연;유선희;박지혜;임수연
    • 핵의학기술
    • /
    • 제23권2호
    • /
    • pp.51-58
    • /
    • 2019
  • 핵의학 체외 검사실 에서는 시약 Lot가 변경될 때, Lot 간의 결과가 신뢰성이 있는지를 판단하기 위해 Lot 간 동등성 검사(comparability test between reagent lots) 또는 시약 병행 검사(reagent parallel test)를 시행하는데, 다수의 국내 검사실에서는 두 lot 간 결과 차이로부터 %difference를 구하여 저농도에서는 20% 이내, 중 고농도에서는 10% 이내로 설정하고 있으며 범위를 벗어 날 경우 재검사 시행으로 범위를 맞추는 실정이다. 따라서 본원의 핵의학 체외 검사실에서 시행되는 몇 가지 검사를 선정하여 parallel test의 결과를 분석해보았고, 검사별 맞춤 %difference 값 선정에 도움 될 만한 참고 자료를 마련해 보고자 하였다. Thyroid-stimulating hormone(TSH), Free thyroxine(FT4), Carcinoembryonic antigen(CEA), CA-125, Prostate-specific antigen(PSA) 그리고 HBs-Ab, insulin, 7종목에 대해 2018 1월부터 2018년 11월까지의 기간 동안의 시약 lot 변화에 따른 정도 관리 물질의 결과를 분석하였다. TSH, F-T4, CEA, CA-125, PSA의 측정에는 IRMA의 원리를 이용한 RIA-MAT 280 system이 사용되었고, Insulin의 측정에는 TECAN 자동화 분주 장비와 GAMMA-10 측정 장비가 사용되었다. HBs-Ab의 측정에는 HAMILTON 자동화 분주 장비와 GAMMA-10 측정 장비가 사용되었다. 각각 전용 시약과 전용 칼리브레이터, 전용 정도 관리 물질이 사용되었다. 1. TSH [%diffrence Max / Mean / Median] (P-value by t-test > 0.05) C-1(저농도) [14.8 / 4.4 / 3.7 / 0.0 ] C-2(중농도) [10.1 / 4.2 / 3.7 / 0.0] 2. FT4 [%diffrence Max / Mean / Median] (P-value by t-test > 0.05) C-1(저농도) [10.0 / 4.2 / 3.9 / 0.0] C-2(고농도) [9.6 / 3.3 / 3.1 / 0.0 ] 3. CA-125 [%diffrence Max / Mean / median] (P-value by t-test > 0.05) C-1(중농도) [9.6 / 4.3 / 4.3 / 0.3] C-2(고농도) [6.5 / 3.5 / 4.3 / 0.4] 4. CEA [%diffrence Max / Mean / median] (P-value by t-test > 0.05) C-1(저농도) [9.8 / 4.2 / 3.0 / 0.0] C-2(중농도) [8.7 / 3.7 / 2.3 / 0.3] 5. PSA [%diffrence Max / Mean / Median] (P-value by t-test > 0.05) C-1(저농도) [15.4 / 7.6 / 8.2 / 0.0] C-2(중농도) [8.8 / 4.5 / 4.8 / 0.9] 6. HBs-Ab [%diffrence Max / Mean / Median] (P-value by t-test > 0.05) C-1(중농도) [9.6 / 3.7 / 2.7 / 0.2] C-2(고농도) [8.9 / 4.1 / 3.6 / 0.3] 7. insulin [%diffrence Max / Mean / Median] (P-value by t-test > 0.05) C-1(중농도) [8.7 / 3.1 / 2.4 / 0.9] C-2(고농도) [8.3 / 3.2 / 1.5 / 0.1] 모두 정도 관리 물질의 lot 변경 시에도 유의미한 차이가 없었으며 표본 수가 늘어남에 따라 검사실과 검사 종목 별 맞춤 허용 기준을 설정할 수 있을 것이라 기대할 수 있었다. 면역 방사 계수 측정법에서 비교적 검출률이 높은 종목들을 선정해서 일 것이라 판단되며 여러 번 재 측정된 결과 값이기 때문일 수도 있겠다. 대부분의 검사 결과에서 허용 기준인 10%에 크게 못 미치는 차이를 보였으며 저농도 target 값을 가진 경우에도 허용 기준인 20%에 가까운 수치를 보이진 않았다. 더 오랜 기간 동안의 관찰과 연구를 통해 평균의 균질화가 이루어진다면 종목 별 검사실 맞춤 허용 기준을 얻을 수 있을 것으로 판단되며 더 다양한 변수를 고려한 관찰과 연구도 필요할 것이다.